135 related articles for article (PubMed ID: 27847477)
1. Reverse of Acute and Chronic Morphine Tolerance by Lithocholic Acid
Yang Z; Li L; Hu H; Xu M; Gu J; Wang ZJ; Yu L; Zeng S
Front Pharmacol; 2016; 7():404. PubMed ID: 27847477
[TBL] [Abstract][Full Text] [Related]
2. The regioselective glucuronidation of morphine by dimerized human UGT2B7, 1A1, 1A9 and their allelic variants.
Yang ZZ; Li L; Wang L; Yuan LM; Xu MC; Gu JK; Jiang HD; Yu LS; Zeng S
Acta Pharmacol Sin; 2017 Aug; 38(8):1184-1194. PubMed ID: 28552915
[TBL] [Abstract][Full Text] [Related]
3. Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapy.
Holthe M; Klepstad P; Zahlsen K; Borchgrevink PC; Hagen L; Dale O; Kaasa S; Krokan HE; Skorpen F
Eur J Clin Pharmacol; 2002 Aug; 58(5):353-6. PubMed ID: 12185559
[TBL] [Abstract][Full Text] [Related]
4. Brain-derived neurotrophic factor involved epigenetic repression of UGT2B7 in colorectal carcinoma: A mechanism to alter morphine glucuronidation in tumor.
Yang ZZ; Li L; Xu MC; Ju HX; Hao M; Gu JK; Jim Wang ZJ; Jiang HD; Yu LS; Zeng S
Oncotarget; 2017 Apr; 8(17):29138-29150. PubMed ID: 28418861
[TBL] [Abstract][Full Text] [Related]
5. Morphine metabolites.
Christrup LL
Acta Anaesthesiol Scand; 1997 Jan; 41(1 Pt 2):116-22. PubMed ID: 9061094
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous assay of morphine, morphine-3-glucuronide and morphine-6-glucuronide in human plasma using normal-phase liquid chromatography-tandem mass spectrometry with a silica column and an aqueous organic mobile phase.
Naidong W; Lee JW; Jiang X; Wehling M; Hulse JD; Lin PP
J Chromatogr B Biomed Sci Appl; 1999 Dec; 735(2):255-69. PubMed ID: 10670739
[TBL] [Abstract][Full Text] [Related]
7. Isoform selectivity and kinetics of morphine 3- and 6-glucuronidation by human udp-glucuronosyltransferases: evidence for atypical glucuronidation kinetics by UGT2B7.
Stone AN; Mackenzie PI; Galetin A; Houston JB; Miners JO
Drug Metab Dispos; 2003 Sep; 31(9):1086-9. PubMed ID: 12920162
[TBL] [Abstract][Full Text] [Related]
8. siRNA capsulated brain-targeted nanoparticles specifically knock down OATP2B1 in mice: a mechanism for acute morphine tolerance suppression.
Yang ZZ; Li L; Wang L; Xu MC; An S; Jiang C; Gu JK; Wang ZJ; Yu LS; Zeng S
Sci Rep; 2016 Sep; 6():33338. PubMed ID: 27629937
[TBL] [Abstract][Full Text] [Related]
9. Morphine glucuronidation and glucosidation represent complementary metabolic pathways that are both catalyzed by UDP-glucuronosyltransferase 2B7: kinetic, inhibition, and molecular modeling studies.
Chau N; Elliot DJ; Lewis BC; Burns K; Johnston MR; Mackenzie PI; Miners JO
J Pharmacol Exp Ther; 2014 Apr; 349(1):126-37. PubMed ID: 24459244
[TBL] [Abstract][Full Text] [Related]
10. Determination of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in plasma after intravenous and intrathecal morphine administration using HPLC with electrospray ionization and tandem mass spectrometry.
Slawson MH; Crouch DJ; Andrenyak DM; Rollins DE; Lu JK; Bailey PL
J Anal Toxicol; 1999 Oct; 23(6):468-73. PubMed ID: 10517552
[TBL] [Abstract][Full Text] [Related]
11. Sex-dependent influences of morphine and its metabolites on pain sensitivity in the rat.
Doyle HH; Murphy AZ
Physiol Behav; 2018 Apr; 187():32-41. PubMed ID: 29199028
[TBL] [Abstract][Full Text] [Related]
12. Morphine-6-O-beta-D-glucuronide but not morphine-3-O-beta-D-glucuronide binds to mu-, delta- and kappa- specific opioid binding sites in cerebral membranes.
Löser SV; Meyer J; Freudenthaler S; Sattler M; Desel C; Meineke I; Gundert-Remy U
Naunyn Schmiedebergs Arch Pharmacol; 1996 Jul; 354(2):192-7. PubMed ID: 8857597
[TBL] [Abstract][Full Text] [Related]
13. Quantitation of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in plasma and cerebrospinal fluid using solid-phase extraction and high-performance liquid chromatography with electrochemical detection.
Wright AW; Watt JA; Kennedy M; Cramond T; Smith MT
Ther Drug Monit; 1994 Apr; 16(2):200-8. PubMed ID: 8009570
[TBL] [Abstract][Full Text] [Related]
14. Effects of morphine glucuronides on the function of opioid receptors in human SK-N-SH cells.
Baker L; Dye A; Ratka A
Neurosci Lett; 2000 Mar; 281(1):1-4. PubMed ID: 10686401
[TBL] [Abstract][Full Text] [Related]
15. A novel functional polymorphism in the uridine diphosphate-glucuronosyltransferase 2B7 promoter with significant impact on promoter activity.
Duguay Y; Báár C; Skorpen F; Guillemette C
Clin Pharmacol Ther; 2004 Mar; 75(3):223-33. PubMed ID: 15001974
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the disposition of hepatically-generated morphine-3-glucuronide and morphine-6-glucuronide in isolated perfused liver from the guinea pig.
Milne RW; Jensen RH; Larsen C; Evans AM; Nation RL
Pharm Res; 1997 Aug; 14(8):1014-8. PubMed ID: 9279882
[TBL] [Abstract][Full Text] [Related]
17. An automatic 96-well solid phase extraction and liquid chromatography-tandem mass spectrometry method for the analysis of morphine, morphine-3-glucuronide and morphine-6-glucuronide in human plasma.
Shou WZ; Pelzer M; Addison T; Jiang X; Naidong W
J Pharm Biomed Anal; 2002 Jan; 27(1-2):143-52. PubMed ID: 11682220
[TBL] [Abstract][Full Text] [Related]
18. Lithocholic acid decreases expression of UGT2B7 in Caco-2 cells: a potential role for a negative farnesoid X receptor response element.
Lu Y; Heydel JM; Li X; Bratton S; Lindblom T; Radominska-Pandya A
Drug Metab Dispos; 2005 Jul; 33(7):937-46. PubMed ID: 15821044
[TBL] [Abstract][Full Text] [Related]
19. Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7.
Innocenti F; Iyer L; Ramírez J; Green MD; Ratain MJ
Drug Metab Dispos; 2001 May; 29(5):686-92. PubMed ID: 11302935
[TBL] [Abstract][Full Text] [Related]
20. High levels of morphine-6-glucuronide in street heroin addicts.
Antonilli L; Semeraro F; Suriano C; Signore L; Nencini P
Psychopharmacology (Berl); 2003 Nov; 170(2):200-4. PubMed ID: 12774191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
